A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K

NCT01364974 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Pharmacokinetics of ASP015K
Pharmacodynamics

Interventions

DRUG: ASP015K
DRUG: Placebo

Sponsor

Astellas Pharma Inc